Cargando…
Dendritic Cells Transduced to Express Interleukin 4 Reduce Diabetes Onset in Both Normoglycemic and Prediabetic Nonobese Diabetic Mice
BACKGROUND: We and others have previously demonstrated that treatment with bone marrow derived DC genetically modified to express IL-4 reduce disease pathology in mouse models of collagen-induced arthritis and delayed-type hypersensitivity. Moreover, treatment of normoglycemic NOD mice with bone mar...
Autores principales: | Ruffner, Melanie A., Robbins, Paul D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912295/ https://www.ncbi.nlm.nih.gov/pubmed/20686610 http://dx.doi.org/10.1371/journal.pone.0011848 |
Ejemplares similares
-
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
Publicado: (1993) -
Reduced Incidence and Delayed Onset of Diabetes in Perforin-deficient Nonobese Diabetic Mice
por: Kägi, David, et al.
Publicado: (1997) -
Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes
por: Nyenwe, Ebenezer, et al.
Publicado: (2020) -
Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
Publicado: (1996) -
Nonobese, Nonketotic Childhood-Onset Diabetes: Look for Lipodystrophies
por: Chakraborty, Partha P., et al.
Publicado: (2017)